Common Contracts
10 similar Registration Rights Agreement contracts by Armata Pharmaceuticals, Inc., Entasis Therapeutics Holdings Inc., DarioHealth Corp.
ARMATA PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 13th, 2023 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 9, 2023, by and between Armata Pharmaceuticals, Inc., a Washington corporation (the “Company”), and Innoviva Strategic Opportunities LLC, a Delaware limited liability company (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 13th, 2022 • DarioHealth Corp. • Surgical & medical instruments & apparatus • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 9, 2022, by and between DarioHealth Corp., a Delaware corporation (the “Company”), and OrbiMed Royalty & Credit Opportunities III, LP (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.” Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Credit Agreement.
ARMATA PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 11th, 2022 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 9, 2022, by and between Armata Pharmaceuticals, Inc., a Washington corporation (the “Company”), and Innoviva Strategic Opportunities LLC, a Delaware limited liability company (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.”
ARMATA PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 29th, 2021 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of October 28, 2021, by and between Armata Pharmaceuticals, Inc., a Washington corporation (the “Company”), Innoviva Strategic Opportunities LLC (“Innoviva”) and Cystic Fibrosis Foundation, a Delaware corporation (“CFF” and together with Innoviva, each a “Holder” or collectively, the “Holders”). The Company and the Holders are referred to each as a “Party” and collectively herein as the “Parties.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 3rd, 2021 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 3, 2021, by and between Entasis Therapeutics Holdings Inc., a Delaware corporation (the “Company”), and Innoviva Strategic Opportunities LLC (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.” Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement.
ARMATA PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 27th, 2021 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January 26, 2021, by and between Armata Pharmaceuticals, Inc., a Washington corporation (the “Company”), and Innoviva Strategic Opportunities LLC (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 22nd, 2020 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 22, 2020, by and between Entasis Therapeutics Holdings Inc., a Delaware corporation (the “Company”), and Innoviva, Inc. (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.” Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 13th, 2020 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April [•], 2020, by and between Entasis Therapeutics Holdings Inc., a Delaware corporation (the “Company”), and Innoviva, Inc. (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.” Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement.
ARMATA PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 13th, 2020 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 12, 2020, by and between Armata Pharmaceuticals, Inc., a Washington corporation (the “Company”), and Innoviva, Inc. (the “Holder”). The Company and the Holder are referred to each as a “Party” and collectively herein as the “Parties.”
ARMATA PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 10th, 2019 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Washington
This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 9, 2019, by and among Armata Pharmaceuticals, Inc., a Washington corporation (the “Company”), and the other parties hereto (each, a “Holder” and collectively, the “Holders”). The Company and the Holders are referred to collectively herein as the “Parties.”
